Based on recent data, Black Diamond Therapeutics, Inc. (BDTX) shows an Average True Range (ATR) of 0.14 and an Enterprise Value of 230.77M. Its average trading volume over the past 3 months is 1.09M, indicating liquidity. These fundamental metrics provide insight into BDTX's underlying financial health and market activity.
| ATR | 0.14 |
| Enterprise Value | 230.77M |
| Avg Vol (3 Months) | 1.09M |
| Avg Vol (10 Days) | 509.63K |
Black Diamond Therapeutics, Inc. (BDTX) technical indicators as of September 15, 2026: the SMA 20 is 5.7%, SMA 50 at -0.31%, and SMA 200 at -14.58%. The RSI 14 value is 53.12, suggesting its current momentum. These technical analysis signals help assess BDTX's price trends and potential future movements.
| SMA 20 | 5.7% |
| SMA 50 | -0.31% |
| SMA 200 | -14.58% |
| RSI 14 | 53.12 |
Black Diamond Therapeutics, Inc. (BDTX) stock performance overview as of September 15, 2026: The 52-week high is $4.94 (currently -49.39% below), and the 52-week low is $1.6 (currently 109.21% above). Over the past year, BDTX's performance is 8.6%, compared to the S&P 500's 0.31% change.
| 52-Week High | 4.94 |
| 52-Week High Chg | -49.39% |
| 52-Week Low | 1.6 |
| 52-Week Low Chg | +109.21% |
| S&P 500 52-Week Chg | 0.31% |
According to market data, Black Diamond Therapeutics, Inc. (BDTX) stock's recent performance metrics show that over the last month, BDTX is -7.34%, with a Year-to-Date (YTD) performance of -1.23%. Over the past year, the stock has seen a 8.6% change. These figures summarize BDTX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 2.15 | 2.32 | 2.32 | 3.97 | 4.94 | 3.97 |
| Low | 1.92 | 1.92 | 1.6 | 1.6 | 1.6 | 1.6 |
| Performance | -9.09% | -7.34% | -40.15% | -23.81% | +8.60% | -1.23% |
According to current financial data, BDTX stock's P/E (TTM) ratio is -2.74, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.25. Key valuation ratios for BDTX, including P/S (N/A), P/B (1.21), and P/FCF (-3.63), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | BDTX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -2.74 | -1.25 | -194.38 | 32.59 |
| P/S (TTM) | N/A | 3.74 | 467.58 | 5.98 |
| P/B (TTM) | 1.21 | 1.18 | 15.57 | 5.6 |
| P/FCF (TTM) | -3.63 | -2.24 | -700.33 | 28.75 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep